An Open-Label Exploratory Phase 2/3 Study of Nivolumab with Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Metastatic Colorectal Cancer

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
An Open-Label Exploratory Phase 2/3 Study of Nivolumab with Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Metastatic Colorectal Cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.